Tracey L. McCain
2018
Compensation breakdown
| Non-Equity Incentive Plan | $176,890 |
|---|---|
| Option Awards | $2,037,606 |
| Salary | $425,216 |
| Other | $8,250 |
| Total | $2,647,962 |
McCain received $2M in option awards, accounting for 77% of the total pay in 2018.
McCain also received $176.9K in non-equity incentive plan, $425.2K in salary and $8.3K in other compensation.
Rankings
In 2018, Tracey L. McCain's compensation ranked 4,410th out of 14,244 executives tracked by ExecPay. In other words, McCain earned more than 69.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,410 out of 14,244 | 69th |
Division Manufacturing | 1,644 out of 5,765 | 72nd |
Major group Chemicals And Allied Products | 590 out of 2,128 | 72nd |
Industry group Drugs | 494 out of 1,817 | 73rd |
Industry Pharmaceutical Preparations | 386 out of 1,391 | 72nd |
Pay ratio
| Tracey L. McCain's Pay | $2,647,962 |
|---|---|
| Median Employee's Pay | $398,087 |
| Pay Ratio | 7to 1 |
In 2018, the annual total compensation of Tracey L. McCain was $2,647,962.
The annual total compensation of the median employee at Blueprint Medicines was $398,087.
The ratio of Tracey L. McCain's pay to the pay of median employee was therefore 7 to one.
McCain's colleagues
We found five more compensation records of executives who worked with Tracey L. McCain at Blueprint Medicines in 2018.
2018
Jeffrey Albers
Blueprint Medicines
Chief Executive Officer
2018
Christina Rossi
Blueprint Medicines
Chief Commercial Officer
2018
Anthony Boral
Blueprint Medicines
Chief Medical Officer
2018
Kathryn Haviland
Blueprint Medicines
Chief Operating Officer
2018
Michael Landsittel
Blueprint Medicines